(Q39765758)

14 September 2017

1 reference

title

Molsidomine: alternative approaches to treat myocardial ischemia (English)

1 reference

14 September 2017

Nitz RE

1

1 reference

14 September 2017

Fiedler VB

series ordinal

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 1987

1 reference

14 September 2017

1 reference

14 September 2017

7

1 reference

14 September 2017

28-37

1 reference

14 September 2017

1

1 reference

Observations on experimental myocardial ischaemia

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Control of myocardial oxygen consumption: physiologic and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Factors influencing infarct size following experimental coronary artery occlusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Role of delayed intraaortic balloon pumping in treatment of experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Reduction of ischemic injury by nitroglycerin during acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

On the limitation of therapeutic intervention trials in ischemic heart disease: a clinician's viewpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Leukocytes and ischemia-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Influence of sulfinpyrazone and naproxen on infarct size in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Hemodynamic and myocardial effects of long-lasting venodilation in the conscious dog: analysis of molsidomine in comparison with nitrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Increased effective vascular compliance and venous pooling of intravascular volume during sustained venodilation in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Effect of molsidomine on cardiac preload, coronary artery diameter, and coronary resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Molsidomine on cardiovascular leukotriene D4 actions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Comparison of various methods for assessing infarct-size in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Effects of molsidomine on the coronary circulation in anesthetized dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Haemodynamic effects of molsidomin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

The dependence of coronary collateral blood flow on regional vascular resistances. Pharmacological studies with glyceryl trinitrate, adenosine and verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Vasorelaxing actions of molsidomine and its metabolites, in comparison with nitroglycerin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Effects of dihydroergotamine on hemodynamic molsidomine actions in anesthetized dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

The activity of molsidomine in experimental models of ischemic cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Myocardial reactive hyperemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Radioautographic studies in experimental myocardial infarction: profiles of ischemic blood flow and quantification of infarct size in relation to magnitude of ischemic zone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

The role of platelets in thrombotic and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Cardiac and Coronary Prostaglandin Synthesis and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Thrombosis and ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Effects of molsidomine and other NO-containing vasodilators on cyclic GMP formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Cyclic GMP as the mediator of molsidomine-induced vasodilatation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Prostaglandins and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Prostaglandins and prostaglandin inhibitors in ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

Molsidomine prevents post-ischaemic ventricular fibrillation in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1987.TB03503.X

10.1002/J.1875-9114.1987.TB03503.X

21 January 2018

Identifiers

DOI

1 reference

release_iq2yzokjrzg6hjgpqmrwniobd4

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iq2yzokjrzg6hjgpqmrwniobd4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference